参考文献/References:
[1] 万古霉素临床应用剂量专家组. 万古霉素临床应用中国专家共识(2011 版)[J]. 中国新药与临床杂志,2011,30 (8): 561-573.Expert Group of Vancomycin Clinical Dose.Chinese expert consensus on clinical application ofVancomycin[J]. Chinese Journal of New Drugs andClinical Remedies, 2011, 30(8):561-573.
[2] 师亚玲,方志远,李茁,等.万古霉素首次监测与个体化给药后血药浓度未达标的影响因素分析[J].中国药师, 2020,23(2):307-310.SHI Yaling, FANG Zhiyuan, LI Zhuo, et al. Analysisof the related factors in vancomycin concentrations notup to standard after first monitoring and individualizedadministration [J]. China Pharmacist, 2020,23(2):307-310.
[3] HU M W, ANNE L, FORNI T, et al. Measurement ofvancomycin in renally impaired patient samples using anew high-performance liquid chromatography methodwith vitamin B12 internal standard: comparison ofhigh-performance liquid chromatography, emit, andfluorescence polarization immunoassay methods.[J].Therapeutic Drug Monitoring, 1990, 12(6) : 562-569.
[4] 张开礼,李成,李玉珍,等.HPLC 法与微生物法测定人血浆中去甲万古霉素浓度的差异比较[J].中国药房, 2015, 26(26):3655-3657.ZHANG Kaili, LI Cheng, LI Yuzhen, et al. Comparisonof plasma concentration of norvancomycin by HPLCand microbiological method[J]. China Pharmacy, 2015,26(26):3655-3657.
[5] 王敏, 柳航, 金路, 等. 酶放大免疫分析法与二维高效液相色谱法监测万古霉素血药浓度的比较[J].药学与临床研究, 2018, 26(1):26-29.WANG Min, LIU Hang, JIN Lu, et al. Comparisonof EMIT and 2D-HPLC-UV in the quantification ofvancomycin in human plasma[J]. Pharmaceutical andClinical Research, 2018, 26(1):26-29.
[6] 廉江平, 丰航, 方志远, 等.EMIT 与HPLC 法测定肾移植术后患者体内霉酚酸血药浓度结果比较[J].现代检验医学杂志,2017,32(3):74-78.LIAN Jiangping, FENG Hang, FANG Zhiyuan, etal. Research on results of plasma mycophenolicacid concentration detected by EMIT and HPLC inthe patients after renal transplantation[J]. Journal ofModern Laboratory Medicine, 2017, 32(3):74-78.
[7] 何娜, 苏珊, 翟所迪, 等.《中国万古霉素治疗药物监测指南(2020 更新版)》解读[J]. 临床药物治疗杂志, 2021,19(1):12-16.HE Na, SU Shan, ZHAI Suodi, et al. Evidencebasedguideline for therapeutic drug monitoring ofvancomycin:2020 update[J]. Clinical MedicationJournal, 2021,19(1):12-16.
[8] 乔小云, 朱怀军, 王羽.酶放大免疫分析法监测万古霉素血药浓度的质控评估[J]. 药学与临床研究,2013, 21(5):516-519.QIAO Xiaoyun, ZHU Huaijun, WANG Yu. Evaluationof quality control for the therapeutic drug monitoringof vancomycin by the enzyme-multiplied immunoassaytechnique[J]. Pharmaceutical and Clinical Research,2013, 21(5):516-519.
[9] 周清武.EMIT 法检测环孢素血药浓度的动态飘逸校正系数研究[J].中国药房 , 2018, 29(8):1078-1082.ZHOU Qingwu. Study on dynamic upwarp statecorrection coefficient of Cyclosporine bloodconcentration determined by EMIT[J]. ChinaPharmacy , 2018, 29(8):1078-1082.
[10] 刘焕君,张蕊,李荣,等.LC-MS/MS 法测定人血浆霉酚酸浓度及与EMIT 法的相关性分析[J].中国临床药理学杂志, 2020, 36(22):3802-3806.LIU Huanjun, ZHANG Rui, LI Rong, et al. Determinationof mycophenolic acid in human plasma by LC -MS /MS and its correlation with EMIT[J]. The Chinese Journalof Clinical Pharmacology, 2020, 36(22):3802-3806.
[11] 徐霞, 纪松岗, 侯翔宇, 等.EMIT 法与HPLC 法测定人全血环孢素谷浓度的比较[J]. 中国药师, 2014,17(12):2003-2006.XU Xia,JI Songgang,HOU Xiangyu,et al. Comparativestudy on concentration monitoring of CsA in humanwhole blood by EMIT and HPLC[J]. China Pharmacist,2014, 17(12):2003-2006.
[12] 王玲萍, 许中, 陆茜莹, 等. 干式时间分辨荧光免疫层析法检测血清抗链球菌溶血素“O”的方法学性能验证[J]. 现代检验医学杂志, 2020, 35(5):131-133,167.WANG Lingping,XU Zhong,LU Qianying,etal. Validation of dry time-resolved fluorescenceimmunochromatography for detection of serum antistreptolysin”O” [J]. Journal of Modern LaboratoryMedicine, 2020, 35(5):131-133,167.